GlaxoSmithKline Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 288 Posts
1 2 3 ... 18
E Money Monday
Article By: Vivian Lewis Monday, August 3, 2020 6:25 PM EDT
Today, after the pileup of results last week, markets caught their breath and rose. We had good news from a Japanese favorite, bad news from a British bank we sold, and good news for a Chinese firm.The Dow is up too.
In this article: GSK, NIO, ITRN, MSFT, QCOM, TEVA, ZYME
Read
The Trump Effect: How Trump's Policies Moved Stocks This Past Week
Article By: The Fly Sunday, August 2, 2020 8:45 AM EDT
Trump says drug prices to be "lowered massively," Chinese-backed hackers reportedly behind Moderna attack.
In this article: L, AZN, BMY, GSK, JNJ, LLY, MRK, NVS, PFE, SNY, RHHBY, AAPL, AMZN, GOOG, MSFT, MRNA, SNAP, FB, TWTR, GOOGL, KODK
Read
FTSE 100 Pushing Down On Support As GBP/USD Strength Weighs
Article By: DailyFX Saturday, August 1, 2020 6:07 PM EDT
The FTSE 100 continues to slide lower and is testing the lower end of the recent trading range. The UK big board has oscillated in a rough 350 point trading zone with the lower bound around 5,930 currently under pressure.
In this article: AZN, BP, GSK, RDS-A, FXB
Read
Ten Best And Worst Performing Biotech Stocks Amid Covid-19
Article By: ValueWalk Monday, July 20, 2020 12:00 PM EDT
Here we take a look at the top ten best and worst performing biotech stocks this year. Novavax is up more than 2000% YTD.
In this article: GSK, VRTX, MRK, NVS, BMY, BIO, JNJ
Read
GlaxoSmithKline To Acquire 10% Stake In Germany's CureVac, Collaborate On 5 MRNA Vaccines
Article By: Benzinga Monday, July 20, 2020 6:15 AM EDT
GlaxoSmithKline plc is acquiring a 10% stake in German biopharmaceutical company CureVac, it announced Monday (London time).
In this article: GSK
Read
These Are Some Of The Coronavirus Vaccine Candidates
Article By: ValueWalk Monday, May 25, 2020 6:28 PM EDT
As far as which coronavirus vaccine candidates will be tested first, researchers will look at production capacity and the amount of immune response generated in early trials and animal studies.
In this article: GSK, PFE, SNY, MRNA, ALT, JNJ, SVA, NVAX, INO, AZN
Read
Profit From The Genomics Market Momentum With These ETFs
Article By: Zacks Investment Research Saturday, May 23, 2020 7:04 PM EDT
It appears that growing demand for personalized medicine, solid investments and higher R&D activities can make genomics the next big thing in the investing space. We highlight a host of ETFs that investors can keep tabs on.
In this article: GSK, GNOM, PBE, ARKG, IDNA
Read
E Daily Stock Pick: GlaxoSmithKline
Article By: Fredrik Arnold Thursday, May 14, 2020 5:56 AM EDT
Glaxo's price per share closed at $42.90 yesterday. A year ago their price was $39.21.
In this article: GSK
Read
Glaxo (GSK) Beats Earnings & Revenue Estimates In Q1
Article By: Zacks Investment Research Wednesday, April 29, 2020 9:45 AM EDT
Glaxo reported core earnings of 93 cents per American depositary share in the first quarter of 2020, which beat our consensus estimate of 79 cents.
In this article: GSK
Read
E Staying Long Against High-Frequency Traders
Article By: James Gornick Wednesday, April 22, 2020 11:10 AM EDT
Time to send the message for the Institutional Investors to run back into ownership--long positions, and bring the bullish goring of the short-selling bears on $INO to break their trading funds within their banks.
In this article: GSK, SNY, INO Also: REGN, MRNA
Read
Week In Review: CICC Capital Closes $229 Million China Fund For Biologics
Article By: ChinaBio® Today Saturday, February 29, 2020 1:50 PM EDT
CICC Capital closed a $229 million investment fund for biologics, with investments coming mainly from Chinese organizations inside and outside the biopharma industry. Some of the money will go to companies making COVID-19 vaccines and therapies.
In this article: AZN, GSK, PFE, GILD, MRNA, BGNE, VIR
Read
Dividend Income Update January 2020
Article By: Keith Park Sunday, February 9, 2020 7:02 PM EDT
With February already underway it is time for all dividend income investors to look back at the previous month and see how much passive dividend income our portfolios generated.
In this article: BNS, CAH, CB, GE, GSK, ITW, JCI, KMB, LTC, MO, PEP, TD, VTR, MDLZ, PM
Read
Glaxo Misses Earnings & Revenue Estimates In Q4
Article By: Zacks Investment Research Wednesday, February 5, 2020 10:02 AM EDT
Glaxo reported core earnings of 65 cents per American depositary share in the fourth quarter of 2019.
In this article: GSK
Read
E Back In Red Ink
Article By: Vivian Lewis Thursday, January 30, 2020 10:18 PM EDT
It's a terrible Thursday with so much uncertainty in the air. Between the Coronavirus, the Trump impeachment, and which Democrat will be a presidential contender, it can be harder than ever to find the right stocks to buy. But I'm here to help...
In this article: RDS-B, RDS-A, CZZ, NIO, VOD, NTDOY, SAN, VRGDF, FBASF, BP, GSK, NOK, RDY, TTM, ESALY, FANUY, JMPLY, OROCF, RHHBY, RNSHF, TCEHY, MELI, TEVA
Read
The 5 Best Biotech Stocks To Buy In 2020
Article By: Money Morning Monday, January 6, 2020 6:17 AM EDT
One of the sectors with higher risk and the highest reward is biotech. Over the last 10 years, the biotech sector has produced nearly 20% annualized gains. Here are our picks for 2020.
In this article: BMY, GSK, LGND, AMGN, BIIB
Read
E Boris Bounce; Trump Tripwire
Article By: Vivian Lewis Sunday, December 15, 2019 5:30 PM EDT
Boris Johnson beat the pollsters handily and Britain went into holiday mode. Meanwhile back on Capitol Hill, the on-again-off-again trade deal with China was on again on. The drug price limits bill is dead in the water which will boost pharma stocks.
In this article: BLRX, LLY, RHHBY, EXEL, GSK, BVNRY, CZZ, IRL, MXE, NOK, SLB, MXCHF, NPSNY, TCEHY, HOLI, AQN, PROSY
Read
1 to 16 of 288 Posts
1 2 3 ... 18